Literature DB >> 11154009

Use of the Ilizarov external fixator in the treatment of patients with Ollier's disease.

R Jesus-Garcia1, J C Bongiovanni, M Korukian, H Boatto, M T Seixas, J Laredo.   

Abstract

The authors present the results of treatment of 10 patients with Ollier's disease using the Ilizarov technique. The Ilizarov device was used to treat leg length discrepancy and to enhance the conversion of chondroma cartilage into normal mature bone, with no curettage and bone grafting. The mean duration of treatment was 9.4 months. This technique was highly efficient in treating the disease. It led to conversion of the abnormal cartilage into histologically mature bone in all patients. Some complications were seen, such as decreased knee mobility, which required prolonged use of the device. The Ilizarov technique is successful in treating patients with Ollier's disease despite some complications and the difficulty in using the technique.

Entities:  

Mesh:

Year:  2001        PMID: 11154009     DOI: 10.1097/00003086-200101000-00013

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

1.  Recurrence of a Unicameral Bone Cyst in the Femoral Diaphysis.

Authors:  Hyun Se Kim; Kyung Sup Lim; Sung Wook Seo; Seung Pil Jang; Jong Sup Shim
Journal:  Clin Orthop Surg       Date:  2016-11-04

2.  Limb reconstruction in Ollier's disease.

Authors:  S S Madan; K Robinson; P D Kasliwal; M J Bell; M Saleh; J A Fernandes
Journal:  Strategies Trauma Limb Reconstr       Date:  2015-04-10

3.  External fixation reconstruction of the residual problems of benign bone tumours.

Authors:  Levent Eralp; F Erkal Bilen; S Robert Rozbruch; Mehmet Kocaoglu; Ahmed I Hammoudi
Journal:  Strategies Trauma Limb Reconstr       Date:  2016-02-12

4.  Limb Length Discrepancy and Angular Deformity due to Benign Bone Tumors and Tumor-like Lesions.

Authors:  Taylor J Reif; Julia Matthias; Austin T Fragomen; S Robert Rozbruch
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2021-03-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.